Literature DB >> 3610485

Comparison of two cognitive rating scales in medically ill patients.

E A Burch, S R Andrews.   

Abstract

Patients with acute, complex behavioral syndromes combined with impaired comprehension and communication are difficult diagnostic challenges. Using a structured mental status interview can significantly reduce the chance of overlooking the presence of cognitive dysfunction. The authors tested the applicability of the cognitive portion of the Alzheimer's Disease Assessment Scale (ADAS-COG) as a screening instrument on a psychiatric consultation service. The ADAS-COG compared favorably with the Mini-Mental State Exam (MMSE), but appeared to be less influenced by educational level. The advantages and disadvantages of using each of these tests on a psychiatric consultation service are discussed.

Entities:  

Mesh：

Year:  1987        PMID： 3610485     DOI： 10.2190/gcvn-d2lj-aph3-kn0k

Source DB:  PubMed          Journal:  Int J Psychiatry Med        ISSN： 0091-2174            Impact factor:   1.210


  7 in total

1.  Cholinesterase inhibitors as adjunctive therapy in patients with schizophrenia and schizoaffective disorder: a review and meta-analysis of the literature.

Authors:  Salma R I Ribeiz; Débora P Bassitt; Jony A Arrais; Renata Avila; David C Steffens; Cássio M C Bottino
Journal:  CNS Drugs       Date:  2010-04       Impact factor: 5.749

Review 2.  Systemic and brain metabolic dysfunction as a new paradigm for approaching Alzheimer's dementia.

Authors:  Vincenzo Giordano; Gianfranco Peluso; Maurizio Iannuccelli; Paola Benatti; Raffaella Nicolai; Menotti Calvani
Journal:  Neurochem Res       Date:  2006-08-17       Impact factor: 3.996

Review 3.  Correlates of response to acetylcholinesterase inhibitor therapy in Alzheimer's disease.

Authors:  Krista L Lanctôt; Nathan Herrmann; Maysoon M LouLou
Journal:  J Psychiatry Neurosci       Date:  2003-01       Impact factor: 6.186

Review 4.  Cognitive dysfunctions in schizophrenia: potential benefits of cholinesterase inhibitor adjunctive therapy.

Authors:  Florian Ferreri; Catherine Agbokou; Serge Gauthier
Journal:  J Psychiatry Neurosci       Date:  2006-11       Impact factor: 6.186

5.  The effect of stimulation therapy and donepezil on cognitive function in Alzheimer's disease. A community based RCT with a two-by-two factorial design.

Authors:  Fred Andersen; Matti Viitanen; Dag S Halvorsen; Bjørn Straume; Tom Wilsgaard; Torgeir A Engstad
Journal:  BMC Neurol       Date:  2012-07-19       Impact factor: 2.474

6.  Co-morbidity and drug treatment in Alzheimer's disease. A cross sectional study of participants in the dementia study in northern Norway.

Authors:  Fred Andersen; Matti Viitanen; Dag S Halvorsen; Bjørn Straume; Torgeir A Engstad
Journal:  BMC Geriatr       Date:  2011-10-04       Impact factor: 3.921

7.  Cerebrospinal Aβ11-x and 17-x levels as indicators of mild cognitive impairment and patients' stratification in Alzheimer's disease.

Authors:  J-D Abraham; S Promé; N Salvetat; L Rubrecht; S Cobo; E du Paty; P Galéa; E Mathieu-Dupas; S Ranaldi; C Caillava; G-A Crémer; F Rieunier; P Robert; F Molina; D Laune; F Checler; J Fareh
Journal:  Transl Psychiatry       Date:  2013-07-16       Impact factor: 6.222
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.